Evidence map›Paper›PMID 38099131›Full record

ArticleIndian journal of dermatology

Pilomatricoma Growing at the SARS-CoV-2 mRNA Vaccination Site.

Merve Hatun Erkayman, Melike Güven, Merve Bingöl, Numan Bulut, Rabia Demirtaş

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Indian journal of dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Merve Hatun ErkaymanFrom the Department of Dermatology and Venereology, Ataturk University, Erzurum, Türkiye.
Melike GüvenFrom the Department of Dermatology and Venereology, Ataturk University, Erzurum, Türkiye.
Merve BingölFrom the Department of Dermatology and Venereology, Ataturk University, Erzurum, Türkiye.
Numan BulutDepartment of Pathology, Faculty of Medicine, Ataturk University, Erzurum, Türkiye.
Rabia DemirtaşDepartment of Pathology, Faculty of Medicine, Ataturk University, Erzurum, Türkiye.
Atatürk University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A healthy 21-year-old woman was presented to our outpatient clinic with an asymptomatic swelling on her left arm. She reported the administration of two doses of BNT162b2 mRNA vaccination at the lesion site earlier. The pathology report confirmed the diagnosis of pilomatricoma. Previously, needlestick trauma and various immunisations have been attributed to the development of pilomatricoma. We present this case to emphasise the possible association between BNT162b2 mRNA vaccination and pilomatricoma development. The role of persistent inflammation is also discussed.

Indexed as

Injection site reactionPilomatricomaSARS-CoV-2 vaccination

Identifiers

PMID38099131
PMCPMC10718257
OpenAlexW4389800408

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.